Your browser doesn't support javascript.
loading
Angelman syndrome genotypes manifest varying degrees of clinical severity and developmental impairment.
Keute, Marius; Miller, Meghan T; Krishnan, Michelle L; Sadhwani, Anjali; Chamberlain, Stormy; Thibert, Ronald L; Tan, Wen-Hann; Bird, Lynne M; Hipp, Joerg F.
Afiliação
  • Keute M; Roche Pharma Research and Early Development, Neuroscience and Rare Diseases, Roche Innovation Center Basel, Basel, Switzerland.
  • Miller MT; Department of Neurology, Otto-von-Guericke-University, Magdeburg, Germany.
  • Krishnan ML; Roche Pharma Research and Early Development, Neuroscience and Rare Diseases, Roche Innovation Center Basel, Basel, Switzerland.
  • Sadhwani A; Roche Pharma Research and Early Development, Neuroscience and Rare Diseases, Roche Innovation Center Basel, Basel, Switzerland.
  • Chamberlain S; Department of Psychiatry, Boston Children's Hospital, Boston, MA, USA.
  • Thibert RL; Harvard Medical School, Boston, MA, USA.
  • Tan WH; Department of Genetics and Genome Sciences, University of Connecticut, Farmington, CT, USA.
  • Bird LM; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.
  • Hipp JF; Harvard Medical School, Boston, MA, USA.
Mol Psychiatry ; 26(7): 3625-3633, 2021 07.
Article em En | MEDLINE | ID: mdl-32792659
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome de Angelman Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suíça
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome de Angelman Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suíça